Browse the evidence

Metabolic surgery (bariatric surgery) is recommended for patients with type 2 diabetes and BMI ≥40 kg/m2, or BMI 35.0-39.9 kg/m2 without durable weight loss, and should be considered for BMI 30.0-34.9 kg/m2 without similar improvements, offering superior glycemic control and cardiovascular risk factor reduction compared to lifestyle/medical interventions.

If you have type 2 diabetes and a BMI of 30 or higher, metabolic surgery is a highly effective option, especially if other weight loss methods have failed. It offers superior glycemic control and significant reductions in cardiovascular risk factors. While there are short-term risks, perioperative mortality is low (0.03-0.20%), and the long-term benefits for health and mortality are substantial.

High levels of physical inactivity and consumption of sugary beverages are primary drivers of obesity prevalence in Saudi Arabia, with inactive individuals showing significantly lower risk reduction compared to active males.

Focus on reducing sugary beverage intake and increasing physical activity, even in small amounts, as inactivity is a major driver of obesity in this region.

Antiobesity medications (AOMs) such as semaglutide and tirzepatide significantly reduce energy intake and appetite, necessitating a shift in nutritional focus from caloric restriction alone to ensuring nutrient density and adequate protein intake to prevent lean mass loss and deficiencies.

When starting semaglutide or tirzepatide, your appetite will drop significantly. Do not just eat less; eat smarter. Prioritize protein (aim for 60-75g daily or up to 1.5g per kg of body weight) and nutrient-dense foods like vegetables, lean meats, and whole grains. This protects your muscle and ensures you get necessary vitamins despite eating smaller portions.

Achieving a weight loss of ≥5% is clinically meaningful for improving cardiometabolic risk factors and is the threshold for FDA approval of anti-obesity medications, though greater losses (≥10-15%) are required for remission of conditions like type 2 diabetes and NASH.

Aim for a 5% weight loss as a primary, achievable goal to significantly improve your heart health and metabolic markers. If you have specific conditions like Type 2 Diabetes or NASH, discuss with your doctor if a higher target (10-15%) is needed for remission, but do not let the higher target discourage you from starting with the 5% goal, which brings substantial health benefits.

Lifestyle interventions, specifically a Mediterranean diet and 150-300 minutes of moderate or 75-150 minutes of vigorous exercise weekly, are recommended to induce weight loss and improve cardiovascular risk factors in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Adopt a Mediterranean-style diet focused on reducing total calories, saturated fats, and processed sugars while increasing intake of fish, vegetables, nuts, and fiber. Combine this with at least 150 minutes of moderate exercise (like brisk walking) or 75 minutes of vigorous exercise per week. Aim for a 5-10% reduction in body weight to significantly improve liver health and cardiovascular risk.

Weight loss of 15 kg can induce remission of Type 2 Diabetes in approximately 70% of individuals, and even smaller weight losses (5 kg) improve insulin sensitivity and glycemic control, highlighting the primacy of lifestyle interventions in diabesity management.

Losing weight is the most powerful tool for managing Type 2 Diabetes. Losing 15 kg can put diabetes into remission for about 70% of people. Even losing 5 kg improves how your body uses insulin. To succeed, combine dietary changes (like Mediterranean or low-carb diets) with regular exercise. Focus on stepwise, realistic goals rather than quick fixes to ensure long-term success.

Lifestyle interventions achieving 7-10% body weight loss are effective in resolving nonalcoholic steatohepatitis (NASH) and regressing fibrosis in patients with metabolic-associated fatty liver disease (MAFLD).

To reverse liver inflammation and fibrosis, you need to lose 7-10% of your body weight through diet and exercise. Losing more than 10% can even reverse scarring (fibrosis). The hardest part is sticking with it, as most people fail to reach these targets. Combine a calorie-restricted diet (like the Mediterranean diet) with 150-300 minutes of moderate exercise per week.

Regular physical activity, specifically at least 150 minutes per week of moderate aerobic exercise combined with resistance training, independently improves liver fat, prevents fibrosis and cirrhosis, and reduces mortality in NAFLD patients, even without significant weight loss.

Aim for 150 minutes of moderate exercise per week, such as brisk walking, cycling, or swimming. Add resistance training (weight lifting) if possible. Start with 30 minutes a day if 150 minutes feels overwhelming. Exercise helps your liver directly, even if the scale doesn't move much.

Time-restricted eating combined with resistance training reduces fat mass to a similar extent as habitual diet combined with resistance training, without compromising fat-free mass.

If your goal is simply to lose fat while building muscle, you don't need to restrict your eating window. Eating normally throughout the day with resistance training yields the same fat loss and muscle preservation as an 8-hour eating window, provided you eat enough.

Weight loss of 7-10% of body weight leads to significant resolution of NASH and fibrosis regression in patients with NAFLD.

To reverse fatty liver disease and NASH, you need to lose 7-10% of your body weight. If you have advanced fibrosis, aim for over 10% loss. Start with a daily calorie deficit of 500-1000 kcal and aim for at least 150 minutes of exercise per week. Even losing 3-5% helps reduce liver fat and improves insulin sensitivity, so don't wait for the full 10% to see benefits.

Achieving a weight loss of greater than 5% is independently associated with slower progression of the frailty index in adults with type 2 diabetes, regardless of HbA1c levels.

Losing more than 5% of your body weight is linked to slower physical decline in people with type 2 diabetes. This benefit holds true even if your blood sugar levels don't change drastically. Focus on sustainable weight loss through diet and exercise.

Maintaining a weight loss of ≥7% of initial body weight for a sustained proportion of time (Time in Target Range, TTR) is associated with a significantly lower risk of composite kidney outcomes in patients with overweight/obesity and type 2 diabetes.

For individuals with type 2 diabetes and overweight/obesity, the goal should not just be to lose weight, but to keep it off. Aim to maintain a 7% reduction from your starting weight. Even if you fluctuate, spending more time within this target range significantly lowers your risk of kidney disease. This involves a combination of eating fewer calories and moving more, supported by regular counseling or self-monitoring.

Lifestyle modifications, specifically calorie-restricted diets combined with moderate-intensity aerobic and resistance exercise, are first-line interventions that can induce Type 2 Diabetes remission and improve insulin sensitivity.

Adopt a daily caloric deficit of 500-750 kcal and aim for 150 minutes of moderate exercise (like brisk walking) spread across at least three days, plus resistance training twice a week. This approach is the primary, evidence-based method to manage obesity and potentially reverse Type 2 Diabetes without medication.

Achieving a weight loss of 10% or greater is required to induce type 2 diabetes remission and prevent microvascular disease, chronic kidney disease progression, cardiovascular events, and overall mortality.

To potentially reverse type 2 diabetes and protect your kidneys and heart, aim to lose more than 10% of your body weight. This is a significant amount of weight and is difficult to achieve and maintain through diet and exercise alone due to your body's natural drive to regain weight. You likely need high-efficacy medical interventions (like GLP-1/GIP agonists or bariatric surgery) or intensive lifestyle programs to reach this threshold. Focus on reducing visceral fat and improving adipose tissue function, not just hitting a specific BMI number.

Weight reduction of 5-10% improves metabolic risk factors, while reduction of ≥10-15% consistently improves sleep apnea, reduces new-onset type 2 diabetes, and reduces overall mortality.

Aim for a 5-10% weight loss to improve metabolic markers, and 10-15% or more to significantly impact sleep apnea and mortality. Focus on sustainable energy balance rather than specific diet dogmas, as weight loss itself is the primary driver of remission for conditions like T2DM.

Physical activity of ≥5000 steps per day is a reasonable initial goal for obesity management, with ≥10,000 steps associated with greater weight reduction.

Start with 5000 steps per day. This is achievable and offers health benefits. If you can increase to 10,000 steps, you may see greater weight loss. Use walking as a tool for maintenance and metabolic health, not just calorie burning.

Weight loss of at least 5-10% significantly lowers systolic and diastolic blood pressure in obese individuals, and this effect is independent of the specific weight loss strategy used.

Achieving a 5-10% weight loss can significantly lower blood pressure (5-20 mmHg systolic). This benefit is achieved regardless of the method used (diet, exercise, or medication). Targeting at least 10% weight loss is recommended for most patients to see meaningful improvements in obesity-related complications.

A daily caloric deficit of at least 600 kcal, achieved through dietary intervention, is the foundational mechanism for sustainable weight loss and can induce type 2 diabetes remission.

To lose weight, you must consume fewer calories than you burn. Aim for a daily deficit of 600 kcal. You can achieve this through various diets (Mediterranean, low-carb, etc.), but the key is choosing one you can sustain. If you have type 2 diabetes, a more aggressive low-energy diet under medical supervision may help achieve remission.

Combining a caloric deficit (500–750 kcal/day) with moderate-to-vigorous aerobic exercise (150–420 min/week) is significantly more effective for weight loss than either diet or exercise alone.

To lose significant weight, you must change your diet. Exercise alone rarely leads to major weight loss. Combine a daily caloric deficit of 500-750 calories with 150 minutes of moderate exercise per week for the best results. Aim for 225-420 minutes of exercise weekly if you want to keep the weight off.

Creatine supplementation (3-5 g/day or loading phase) enhances power output and recovery in high-intensity weightlifting by increasing intramuscular phosphocreatine stores.

Take 3-5 grams of creatine daily. If you need faster results, take 20 grams daily for 5-7 days, then drop to 3-5 grams. This increases your muscle's energy stores for explosive lifts.

Bariatric surgery is recommended for eligible patients with noncirrhotic MASLD to achieve sustained weight reduction and remission of type 2 diabetes.

If you have severe obesity and MASLD, discuss bariatric surgery with your doctor. It can lead to significant weight loss and remission of type 2 diabetes, reducing your risk of liver and heart disease.

A 3-month intervention combining alternate day fasting (600 kcal on fast days) and moderate-intensity aerobic exercise significantly reduces intrahepatic triglyceride content and associated cardiometabolic risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

For patients with fatty liver disease, a 3-month program of Alternate Day Fasting (eating 600 calories on fast days, normal on others) combined with 5 weekly sessions of moderate exercise (like brisk walking or cycling) significantly reduces liver fat. This approach is a validated, mainstay therapy that works by creating a caloric deficit and improving metabolic markers, even without drastic daily calorie counting.

Intentional weight loss of 10% or more significantly improves cardiovascular outcomes, including arrhythmic free survival and symptom severity in atrial fibrillation, whereas lesser degrees of weight loss (e.g., 5%) do not show the same benefit.

If you have Atrial Fibrillation and are overweight, aim for a weight loss of at least 10% of your body weight. Small losses (like 5%) may not be enough to significantly improve your heart rhythm or symptoms. Consult your doctor for a structured weight loss plan.

Weight loss of 7-10% of body weight improves the majority of histopathological features of NASH, including fibrosis, achieved through a daily calorie reduction of 500-1000 kcal combined with moderate-intensity exercise.

To improve liver health in NASH, aim to lose 7-10% of your body weight. This is best achieved by eating 500-1000 fewer calories per day and exercising moderately for 150 minutes a week. Even a 3-5% loss helps with liver fat, but the higher target is needed to reverse fibrosis.